Artificial Insemination Market will Grow At a CAGR of 7% by 2026- Exclusive Report by Fact.MR

Growing Public Awareness Regarding Infertility Treatments, Rising Adoption of Affordable & High-Quality Services, And Increase in Funding By Government Organizations for the Development of Healthcare Infrastructure Are Factors Stimulating Market Revenue Growth

United States, Rockville MD, Aug. 05, 2022 (GLOBE NEWSWIRE) -- As per detailed industry analysis by Fact.MR, a market research and competitive intelligence provider, the global artificial insemination market is expected to reach a valuation of US$ 2.5 billion by 2026, rising at a CAGR of 7% over the forecast period (2022-2026).

A method of assisted reproduction known as artificial insemination involves injecting live sperm into the fallopian tubes, cervix, or uterus of a female. Animal breeding routinely uses artificial insemination to increase reproductive success and protect rare and endangered species. Additionally, it aids in preventing the spread of diseases and sterility in animals brought on by genital issues.

For Critical Insights on Artificial Insemination Market, Request a Sample Report

The popularity of artificial insemination techniques increases when regulations are standardized across countries because it makes patients safer. Also, donors' names are kept secret under government regulations. It provides a chance for couples who wish to employ artificial insemination. In developing countries, where roughly 10% of women struggle to conceive and start a family, infertility treatments are difficult to come by. The market will expand if more people are made aware of the issues associated with infertility.

Growing government initiatives to make infertility treatments more accessible, increased focus on healthcare infrastructure upgrades, and rise in the number of fertility clinics are all contributing to the expansion of the artificial insemination market.

How is Artificial Insemination Market Expansion Being Driven?

“Growing Public Awareness about New Technologies for Reproductive Treatments”

The market for artificial insemination is driven by the rising incidence of infertility in both men and women. Because more individuals are developing illnesses such as erectile dysfunction and polycystic ovary syndrome (PCOS), infertility is becoming increasingly prevalent globally.

Problems may arise from alterations in lifestyle and the desire of more working women to have children later in life. Men may find it challenging to become pregnant for a variety of reasons, including stress, alcohol consumption, lifestyle changes, and a decline in sperm quantity and motility.

Artificial insemination is frequently used as the first treatment for infertility, even though in vitro fertilization is thought of as a more sophisticated type of assisted reproductive technology.

Multinational pharmaceutical companies' rapid development of medicines that are undergoing clinical and preclinical research, as well as their release of new insemination kits with established potential advantages, are driving the growth of the artificial insemination market.

A significant opportunity has been generated for this industry by the invention of novel intracytoplasmic sperm injection (ICSI) for kid production, which is implanted in the ovum of females.

To learn more about Artificial Insemination Market, you can get in touch with our Analyst at

Key Segments Covered in the Artificial Insemination Industry Survey

  • By Type :

    • Intrauterine Insemination
    • Intravaginal Insemination
    • Intratubal Insemination
    • Others
  • By Source :

    • AIH-Husband
    • AID-Donor
  • By Facility Type :

    • Hospitals
    • Fertility Centers
    • Home-based

  • By Region :

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Competitive Landscape

Key companies are forming strategic alliances to broaden their product offerings and improve their market share. Market players will exert more effort to develop unique devices that will garner worldwide notice.

Companies are urging regulatory bodies to quickly approve innovative pharmaceuticals and treatment regimens to hasten the introduction of advanced artificial insemination procedures.

For instance,

  • In 2022, Shenandoah Biotechnology was acquired by Fujifilm Irvine Scientific, enabling the localization of cell culture for the production of vaccines and other therapeutics.

Get Customization on Artificial Insemination Market Report for Specific Research Solutions

Key players in the Artificial Insemination Market

  • Rocket Medical PLC
  • Vitrolife AB
  • Genea Limited
  • Pride Angel Ltd.
  • Irvine Scientific
  • Hi-Tech Solutions

Key Takeaways from Artificial Insemination Market Study

  • The global artificial insemination market is currently valued at US$ 1.9 billion.
  • The market in Japan is anticipated to increase at a CAGR of 6.3% through 2026.
  • The market in Canada is projected to increase at a CAGR of 5.5% over the next 4 years.
  • Demand for intravaginal insemination techniques is expected to rise at a CAGR of 6.5% from 2022 to 2026.

Explore Fact.MR's Coverage on the Healthcare Domain-

Tissue Expanders Market- The global tissue expanders market is estimated at USD 668.2 Million in 2022 and is forecast to surpass USD 1,332.9 Million by 2032, growing at a CAGR of 7.1% from 2022 to 2032.

Non-Invasive Aesthetic Treatment Market- The market size of non-invasive aesthetic treatments was around US$ 53.3 Bn in 2021, and it is expected to grow with the compound annual growth rate (CAGR) of 16.5% for the period of 2022 to 2032.

Sacroiliac Joint Fusion Market- The global sacroiliac joint fusion market size is estimated at US$ 620 Mn in 2022 and is likely to reach US$ 3,900 Mn by 2032. The market is expected to witness a CAGR of 20.2% during the forecast period from 2022 to 2032.

Cardiac Resynchronization Therapy Market- Newly-released Cardiac Resynchronization Therapy industry analysis report by Fact.MR shows that global sales of Cardiac Resynchronization Therapy in 2021 were held at US$ 5.7 Bn. With 7.9%, the projected market growth during 2022-2032 is expected to be slightly lower than the historical growth.
Dental Radiology Equipment Market- According to Fact.MR, the global dental radiology equipment market was valued at around US$ 7 Bn in 2020, and is projected to expand 1.4X to top US$ 10 Bn by 2031.

Personal Dental Water Flosser Market- According to Fact.MR’s personal dental water flosser industry research, the global market was valued at US$ 196 Mn in 2020, and is projected to top US$ 292 Mn by 2031, expanding at a CAGR of 6% across the 2021-2031 forecast period.

Dental Diagnostic Imaging Equipment Market- Fact.MR’s dental diagnostic imaging equipment industry research reveals that the global market was valued at US$ 2 Bn in 2020, and is projected to top US$ 3 Bn by 2031, expanding at a CAGR of 6%. Demand for X-ray systems is projected to increase at a CAGR of 5% through 2031, with that for dental cone beam computed tomography surging at 7%.

Dental Membrane and Bone Graft Substitutes Market- According to Fact.MR, the global dental membrane and bone graft substitutes market was valued at around US$ 500 Mn in 2020, and is projected to expand 1.8X to top US$ 900 Mn by 2031.

Interdental Cleaning Products Market- Fact.MR’s interdental cleaning products industry analysis shows that the global market was valued at US$ 3 Bn in 2020, and is projected to top US$ 4 Bn by 2031, expanding at a CAGR of 3%. Demand for interdental brushes is projected to expand at a CAGR of 5%, reaching a valuation of around US$ 1 Bn by 2031, with that for toothpicks is increasing at 4%.

Home Infusion Therapy Market- Newly-released Home Infusion Therapy industry analysis report by Fact.MR shows that global sales of Home Infusion Therapy in 2021 was held at US$ 31 Bn. With 8.6%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Tel: +1 (628) 251-1583
Follow Us: LinkedIn | Twitter